Main > INFECTIOUS DISEASES > CN. A. HCV Infection>Treat.>



CN. A. HCV Infection>Treat.>'s subsections
(*) CN Approval Date: 2020. 07.31
>Ravidasvir+Danoprevir Oral
Company
Patent
TradeMark

CN. A. HCV Infection>Treat.>'s products
This section has no products